PEGYLATED OPIOIDS WITH LOW POTENTIAL FOR ABUSE.

• 1. 具有低滥用潜在性的聚乙二醇化阿片样物质 [P] . 中国专利： CN102159249A . 2011-08-17
• 2. 一种防滥用的阿片类药物口服缓释片及其制备方法 [P] . 中国专利： CN112402386A . 2021-02-26
• 3. PEGYLATED OPIOIDS WITH LOW POTENTIAL FOR ABUSE. [P] . MX2011002748A . 2011-04-21

  机译： 潜在滥用可能性低的聚乙二醇化阿片类药物。

• 4. PEGYLATED OPIOIDS WITH LOW POTENTIAL FOR ABUSE [P] . 欧洲知识产权局专利： EP3342427A1 . 2018-07-04

  机译： 低滥用潜力的聚乙二醇阿片类药物

• 5. PEGYLATED OPIOIDS WITH LOW POTENTIAL FOR ABUSE [P] . 韩国专利： KR101660996B1 . 2016-09-28

  机译： 低滥用潜力的聚乙二醇阿片类药物

• 1. Hesperetin conjugated PEGylated gold nanoparticles exploring the potential role in anti-inflammation and anti-proliferation during diethylnitrosamine-induced hepatocarcinogenesis in rats [J] . Gokuladhas Krishnan, Jayakumar Subramaniyan, Pramila Chengalvarayan Subramani, 亚洲药物制剂科学(英文) . 2017,第005期
• 2. δ-Opioid receptor as a potential therapeutic target for ischemic stroke [J] . Kalpana Subedi, Hongmin Wang 中国神经再生研究（英文版） . 2020,第001期
• 3. Analgesic and anti-inflammatory potential of aerial parts of the Daphne mucronata Royle extract in mice: Opioid-independent action [J] . Zohreh Khodadadian, Majid Hassanpour-Ezatti, Seyed Zahra Mousavi, 亚太热带生物医学杂志（英文版） . 2016,第003期
• 4. Analgesic and anti-inflammatory potential of aerial parts of the Daphne mucronata Royle extract in mice: Opioid-independent action [J] . Zohreh Khodadadian, Majid Hassanpour-Ezatti, Seyed Zahra Mousavi, 亚太热带生物医学杂志：英文版 . 2016,第003期
• 5. Long-term follow-up of HCV patients with sustained virological response after treatment with pegylated interferon plus ribavirin [J] . Yuan-Ji Ma, Ling-Yao Du, Li-Bo Yan, 国际肝胆胰疾病杂志（英文版） . 2021,第002期
• 6. w-15:a new, potential opioid of abuse. [J] . Maurizio Coppola, Raffaella Mondola Journal of opioid management . 2015,第2期
• 7. FDA approvals of generic drugs: impact on the diversion of opioid analgesics with a potential for abuse. [J] . Journal of opioid management . 2009,第2期
• 8. FDA approvals of generic drugs: impact on the diversion of opioid analgesics with a potential for abuse. [J] . Journal of opioid management . 2009,第2期
• 9. QTRAP LC/MS/MS Workflow for Simultaneous Characterization and Quantitation of PEGylated Liposomal Drug Formulation Characterization of precursor lipids and its PEGylated derivatives allows the determination of liposome compositions using QTRAP LC/MS/MS System [C] . Sebastian Fabritz, Cyrus Papan, Pol Harvengt ASMS Conference on Mass Spectrometry and Allied Topics . 2015
• 10. Endomorphin analog analgesics with low abuse liability: Novel therapeutics for pain and opioid abuse. [D] . Nilges, Mark. 2015
• 11. Monepantel considerably enhances the therapeutic potentials of PEGylated liposomal doxorubicin and gemcitabine in ovarian cancer: in vitro and in vivo studies [O] . Parvin Ataie-Kachoie, Krishna Pillai, Samina Badar, 2018
• 12. Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse. [O] . M D Raleigh, S J Peterson, M Laudenbach, 2017

• 1. 单纯强阿片类药物治疗控制癌痛与腹腔内生场热疗联合强阿片类药物治疗控制癌痛的效果比较 [C] . DING Zhao-heng ,丁昭珩 ,YAO Xiao-xiang . 第十三届全国癌症康复与姑息医学大会 . 2017
• 2. 阿片类药物成瘾性受体分布的三维可视化研究 [A] . 徐平 . 2010